Inflammatory bowel disease in families with four or more affected first-degree relatives

References

• Bridger S, Lee JC, Bjarnason I, et al. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn’s disease and non-smokers develop ulcerative colitis. Gut. 2002;51(1):21–25.
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411(6837):599–603.
   PubMed Web of Science ®Google Scholar
• Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype–phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70(4):845–857.
   PubMed Web of Science ®Google Scholar
• Annese V, Lombardi G, Perri F, et al. Variants of CARD15 are associated with an aggressive clinical course of Crohn’s disease – an IG-IBD study. Am J Gastroenterol. 2005;100(1):84–92.
   PubMed Web of Science ®Google Scholar
• Vermeire S, Wild G, Kocher K, et al. CARD15 genetic variation in a Quebec population: prevalence, genotype–phenotype relationship, and haplotype structure. Am J Hum Genet. 2002;71(1):74–83.
   PubMed Web of Science ®Google Scholar
• Helio T, Halme L, Lappalainen M, et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn’s disease. Gut. 2003;52(4):558–562.
   PubMed Web of Science ®Google Scholar
• Halme L, Turunen U, Heliö T, et al. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol. 2002;37(6):692–698.
   PubMed Web of Science ®Google Scholar
• Henriksen M, Jahnsen J, Lygren I, et al. Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study. Am J Gastroenterol. 2007;102(9):1955–1963.
   PubMed Web of Science ®Google Scholar
• Andreu M, Márquez L, Domènech E, et al. Disease severity in familial cases of IBD. J Crohns Colitis. 2014;8(3):234–239.
   PubMed Web of Science ®Google Scholar
• Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn’s disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology. 1996;111(3):597–603.
   PubMed Web of Science ®Google Scholar
• Bayless TM, Tokayer AZ, Polito JM II, et al. Crohn’s disease: concordance for site and clinical type in affected family members – potential hereditary influences. Gastroenterology. 1996;111(3):573–579.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Grootscholten C, Holt H, et al. Clinical patterns of familial inflammatory bowel disease. Gut. 1996;38(5):738–741.
   PubMed Web of Science ®Google Scholar
• GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30.
   PubMed Web of Science ®Google Scholar
• Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl. A):5A–36A.
   PubMed Web of Science ®Google Scholar
• Cho JH, Weaver CT. The genetics of inflammatory bowel disease. Gastroenterology. 2007;133(4):1327–1339.
   PubMed Web of Science ®Google Scholar
• Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991;324(2):84–88.
   PubMed Web of Science ®Google Scholar
• Ben-Horin S, Tamir S, Kopylov U, et al. Familial ulcerative colitis in Israeli Jews: its prevalence and clinical severity compared to sporadic disease. Ann Gastroenterol. 2011;24(4):285–289.
   PubMedGoogle Scholar
• Ben-Horin S, Avidan B, Yanai H, et al. Familial clustering of Crohn’s disease in Israel: prevalence and association with disease severity. Inflamm Bowel Dis. 2009;15(2):171–175.
   PubMed Web of Science ®Google Scholar
• Borren NZ, Conway G, Garber JJ, et al. Differences in clinical course, genetics, and the microbiome between familial and sporadic inflammatory bowel diseases. J Crohns Colitis. 2018;12(5):525–531.
   PubMed Web of Science ®Google Scholar
• Duricova D, Burisch J, Jess T, et al. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis. 2014;8(11):1351–1361.
   PubMed Web of Science ®Google Scholar
• Childers RE, Eluri S, Vazquez C, et al. Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis. J Crohns Colitis. 2014;8(11):1480–1497.
   PubMed Web of Science ®Google Scholar
• Hwang SW, Kwak MS, Kim WS, et al. Influence of a positive family history on the clinical course of inflammatory bowel disease. J Crohns Colitis. 2016;10(9):1024–1032.
   PubMed Web of Science ®Google Scholar
• Yang H, McElree C, Roth MP, et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993;34(4):517–524.
   PubMed Web of Science ®Google Scholar
• Chung SH, Park SJ, Lee HS, et al. Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea. World J Gastroenterol. 2014;20(45):17120–17126.
   PubMed Web of Science ®Google Scholar
• Karmiris K, Avgerinos A, Tavernaraki A, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis. 2016;10(4):429–436.
   PubMed Web of Science ®Google Scholar
• Roma ES, Panayiotou J, Pachoula J, et al. Inflammatory bowel disease in children: the role of a positive family history. Eur J Gastroenterol Hepatol. 2010;22(6):710–715.
   PubMed Web of Science ®Google Scholar
• Lee JC, Lennard-Jones JE. Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives. Gastroenterology. 1996;111(3):587–596.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Pal P, Hutfless S, et al. Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior. Intest Res. 2019;17(4):486–495.
   PubMed Web of Science ®Google Scholar
• Trier Moller F, Andersen V, Andersson M, et al. Hospital admissions, biological therapy, and surgery in familial and sporadic cases of inflammatory bowel disease: a population-based cohort study 1977–2011. Inflamm Bowel Dis. 2015;21(12):2825–2832.
   PubMed Web of Science ®Google Scholar
• Cleynen I, Boucher G, Jostins L, et al. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016;387(10014):156–167.
   PubMed Web of Science ®Google Scholar